Thus, the isocitrate dehydrogenase status, such as IDH-1 and IDH-2 mutations, and ATRX mutation or loss and tumours with 1p19q co-deletion has been associated with better prognosis [27]. This evidence concerns the gene IDH1 and neoplasm.